CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Franchise Global Health Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Franchise Global Health Inc
550 Burrard St #2300
Phone: (778) 847-1880p:778 847-1880 VANCOUVER, BC  V6C 2B5  Canada
This company was Merged or Acquired on 12/23/2022.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Franchise Global Health Inc. is a Canada-based medical cannabis company. The Company, through its subsidiaries, is a multi-national operator in the medical cannabis and pharmaceutical industries, with principal operations in Germany and with operations, assets, strategic partnerships and investments internationally. The Company is focused on medical cannabis operations in genetics, cultivation, and pharma distribution. It operates as a multi-national operator in the medical cannabis and pharmaceutical industries with operations, assets, strategic partnerships and investments in Germany, St. Vincent & the Grenadines, Portugal and Denmark. The Company’s geographical segments include Germany and Denmark. Its subsidiaries include Harmony Health One Inc., ACA Muller, Sativa Verwaltungs GmbH, Sativa Verwaltungs GmbH and Co. KG, CBD Med Therapeutics Inc., Fayber Technologies Canada Inc., Catalunia SAS, Green CannaHealth SAS, Klokken Aarhus Inc., and Rangers Pharmaceuticals A/S.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202212/31/2021Yes----

Industries
SIC Code Description
5912 Drug stores and proprietary stores
2833 Medicinal chemicals and botanical products
0139 Field crops, except cash grains, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer LuisMerchan 3/15/2022 12/16/2020
Chief Financial Officer ElshadGarayev 8/15/2022 8/15/2022
Chief Marketing Officer JessieCasner 3/1/2021 3/1/2021
8 additional Officers and Directors records available in full report.

Business Names
Business Name
FGH
WV4A

General Information
Outstanding Shares: 134,563,674 (As of 9/30/2022)
Stock Exchange: CVE
Email Address: info@franchiseglobalhealth.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 2, 2024